137 related articles for article (PubMed ID: 37831297)
1. Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS).
Tao RE; Pixley JN; Holovach PG; Fleischer AB; Feldman SR
Dermatol Ther (Heidelb); 2023 Dec; 13(12):3221-3227. PubMed ID: 37831297
[TBL] [Abstract][Full Text] [Related]
2. Trends in pediatric psoriasis outpatient health care delivery in the United States.
Vogel SA; Yentzer B; Davis SA; Feldman SR; Cordoro KM
Arch Dermatol; 2012 Jan; 148(1):66-71. PubMed ID: 21931013
[TBL] [Abstract][Full Text] [Related]
3. Off-Label Prescribing for Children with Migraines in U.S. Ambulatory Care Settings.
Lai LL; Koh L; Ho JA; Ting A; Obi A
J Manag Care Spec Pharm; 2017 Mar; 23(3):382-387. PubMed ID: 28230456
[TBL] [Abstract][Full Text] [Related]
4. Patterns of vitamin D analog use for the treatment of psoriasis.
Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
[TBL] [Abstract][Full Text] [Related]
5. Prescribing Patterns for Atopic Dermatitis in the United States.
Pona A; Cline A; Kolli S; Feldman SF; Fleischer AFJ
J Drugs Dermatol; 2019 Oct; 18(10):987-990. PubMed ID: 31584776
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis treatment in the United States at the end of the 20th century.
Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
[TBL] [Abstract][Full Text] [Related]
7. Systemic corticosteroids are frequently prescribed for psoriasis.
Al-Dabagh A; Al-Dabagh R; Davis SA; Taheri A; Lin HC; Balkrishnan R; Feldman SR
J Cutan Med Surg; 2014; 18(3):195-9. PubMed ID: 24800708
[TBL] [Abstract][Full Text] [Related]
8. Trends in older adult psoriasis outpatient health care practices in the United States.
Wong JW; Davis SA; Feldman SR; Koo JY
J Drugs Dermatol; 2012 Aug; 11(8):957-62. PubMed ID: 22859241
[TBL] [Abstract][Full Text] [Related]
9. New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care.
Feldman SR; Fleischer AB; Cooper JZ
Int J Dermatol; 2000 Jan; 39(1):41-4. PubMed ID: 10651966
[TBL] [Abstract][Full Text] [Related]
10. Patient Characteristics and Treatment Patterns in European Pediatric Patients with Psoriasis: A Real-World, Cross-Sectional Study.
Sticherling M; McPherson T; de Lucas Laguna R; Costanzo A; Reed C; Artime E; Robert C; Lucas J; Schuster C; Mahé E
Dermatol Ther (Heidelb); 2022 Aug; 12(8):1793-1808. PubMed ID: 35797001
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis treatments by payment type in the US outpatient office setting.
Mireku K; Huang KE; Narahari S; Davis SA; Feldman SR
J Drugs Dermatol; 2013 Oct; 12(10):1095-7. PubMed ID: 24085043
[TBL] [Abstract][Full Text] [Related]
12. Comparing prescribing patterns for topical corticosteroids based on their FDA indication by age.
Freeze ME; Balogh EA; Cline A; Feldman SR; Fleischer AB
Pediatr Dermatol; 2021 Jan; 38(1):115-118. PubMed ID: 33170543
[TBL] [Abstract][Full Text] [Related]
13. Medication therapy in ambulatory medical care. National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, 1992.
Nelson CR; Knapp DE
Adv Data; 1997 Aug; (290):1-24. PubMed ID: 10182809
[TBL] [Abstract][Full Text] [Related]
14. Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece.
Souliotis K; Golna C; Kani C; Litsa P
J Med Econ; 2016 Nov; 19(11):1021-1026. PubMed ID: 27207488
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis Suppurativa Management in the United States: An Analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases.
Davis SA; Lin HC; Balkrishnan R; Feldman SR
Skin Appendage Disord; 2015 Sep; 1(2):65-73. PubMed ID: 27172455
[TBL] [Abstract][Full Text] [Related]
16. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
[TBL] [Abstract][Full Text] [Related]
17. United States systemic psoriasis treatments: increases in the use of biologic agents and plateau of methotrexate and oral small molecule inhibitors.
Muddasani S; Fleischer AB
J Dermatolog Treat; 2022 Feb; 33(1):143-145. PubMed ID: 32048895
[TBL] [Abstract][Full Text] [Related]
18. Acitretin for the treatment of psoriasis: an assessment of national trends.
Ghasri P; Yentzer BA; Dabade TS; Feldman SR
J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
[TBL] [Abstract][Full Text] [Related]
19. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
Horii KA; Simon SD; Liu DY; Sharma V
Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
[TBL] [Abstract][Full Text] [Related]
20. Class I topical corticosteroid use by psoriasis patients in an academic practice.
Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
